Does ATORVASTATIN\EZETIMIBE Cause Interstitial lung disease? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Interstitial lung disease have been filed in association with ATORVASTATIN\EZETIMIBE. This represents 2.8% of all adverse event reports for ATORVASTATIN\EZETIMIBE.
35
Reports of Interstitial lung disease with ATORVASTATIN\EZETIMIBE
2.8%
of all ATORVASTATIN\EZETIMIBE reports
2
Deaths
24
Hospitalizations
How Dangerous Is Interstitial lung disease From ATORVASTATIN\EZETIMIBE?
Of the 35 reports, 2 (5.7%) resulted in death, 24 (68.6%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN\EZETIMIBE. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN\EZETIMIBE Cause?
Myalgia (130)
Acute kidney injury (60)
Pain (45)
Pain in extremity (43)
Dizziness (42)
Malaise (42)
Pyrexia (41)
Rhabdomyolysis (40)
Arthralgia (39)
Headache (39)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ATORVASTATIN\EZETIMIBE Alternatives Have Lower Interstitial lung disease Risk?
ATORVASTATIN\EZETIMIBE vs ATOSIBAN
ATORVASTATIN\EZETIMIBE vs ATOVAQUONE
ATORVASTATIN\EZETIMIBE vs ATOVAQUONE\PROGUANIL
ATORVASTATIN\EZETIMIBE vs ATRACURIUM
ATORVASTATIN\EZETIMIBE vs ATRIPLA